Showing results (681-690 of 1,873) with videos related to

Sort By:
Pageof 188
Pulmonary Pharmacology & Therapeutics|July 19, 2005
Involvement of guanylyl cyclase, protein kinase A and Na+ K+ ATPase in relaxations of bovine isolated bronchioles induced by GEA 3175, an NO donorB Elmedal Laursen, M J Mulvany, U Simonsen
Pulmonary Pharmacology & Therapeutics|January 24, 2007
Effect of azelastine, montelukast, and their combination on allergen-induced bronchoconstriction in asthmaKai Richter, Lars Grönke, Stanislawa Janicki, et al.
Pulmonary Pharmacology & Therapeutics|October 20, 2006
Influence of pirfenidone on airway hyperresponsiveness and inflammation in a Brown-Norway rat model of asthmaJim K Mansoor, Kendra C Decile, Shri N Giri, et al.
Pulmonary Pharmacology & Therapeutics|July 11, 2006
Selective inhibitors for phosphodiesterase 3 and 4 in antigen-induced increase of cough reflex sensitivity in guinea pigsMasaki Fujimura, Qi Liu
Pulmonary Pharmacology & Therapeutics|May 23, 2006
Propofol exerts protective effects on the acute lung injury induced by endotoxin in ratsChia-Hsiang Chu, Demeral David Liu, Yung-Hsiang Hsu, et al.
Pulmonary Pharmacology & Therapeutics|December 23, 2022
A retro-inverso modified peptide alleviated ovalbumin-induced asthma model by affecting glycerophospholipid and purine metabolism of immune cellsShumei Ma, Kuan Yang, Zhihong Li, et al.
Pulmonary Pharmacology & Therapeutics|December 8, 2022
β-sitosterol targets glucocorticoid receptor to reduce airway inflammation and remodeling in allergic asthmaJianfeng Xu, Lei Yang, Tiantian Lin
Pulmonary Pharmacology & Therapeutics|January 20, 2019
Vitamin D prevents experimental lung fibrosis and predicts survival in patients with idiopathic pulmonary fibrosisVasilios Tzilas, Evangelos Bouros, Ilianna Barbayianni, et al.
Pulmonary Pharmacology & Therapeutics|December 1, 2019
C-reactive protein as a biomarker of response to inhaled corticosteroids among patients with COPDOlorunfemi A Oshagbemi, Frits M E Franssen, Emiel F M Wouters, et al.
Pulmonary Pharmacology & Therapeutics|July 17, 2021
Efficacy and safety of combined isoniazid-rifampicin-pyrazinamide-levofloxacin dry powder inhaler in treatment of pulmonary tuberculosis: A randomized controlled trialNisa Laohapojanart, Chaveewan Ratanajamit, Kamon Kawkitinarong, et al.
Pageof 188